These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2754561)

  • 1. Late hyporegenerative anemia in Rh hemolytic disease.
    Koenig JM; Ashton RD; De Vore GR; Christensen RD
    J Pediatr; 1989 Aug; 115(2):315-8. PubMed ID: 2754561
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.
    Pessler F; Hart D
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):689-93. PubMed ID: 12439047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.
    Alaqeel AA
    Pan Afr Med J; 2019; 32():120. PubMed ID: 31223410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease.
    Thorp JA; O'Connor T; Callenbach J; Cohen GR; Yeast JD; Albin J; Plapp F
    Am J Obstet Gynecol; 1991 Jul; 165(1):79-81. PubMed ID: 1853921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia.
    Christensen RD; Hunter DD; Goodell H; Rothstein G
    J Pediatr; 1992 Apr; 120(4 Pt 1):593-8. PubMed ID: 1552400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S; al Omran A
    J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Rh(c), "little c," isoimmunization: the role of rHuEpo in preventing late anemia.
    Zuppa AA; Cardiello V; Alighieri G; Cota F; D'Antuono A; Riccardi R; Catenazzi P; Romagnoli C
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):e269-71. PubMed ID: 23073047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F; Samanci N; Dağoğlu T
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic Anemia and Heart Failure Caused by Anti-C and Anti-E Immunization.
    Bilgin H; Eren A; Kara S
    J Coll Physicians Surg Pak; 2016 Jun; 26(6):539-40. PubMed ID: 27353998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
    Dorn I; Schlenke P; Härtel C
    Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.
    Ohls RK; Wirkus PE; Christensen RD
    Pediatrics; 1992 Nov; 90(5):678-80. PubMed ID: 1408538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Titers and hemolytic late effects of rhesus antibodies in exchange transfusion in newborn infants with hemolytic anemia due to the rhesus factor].
    Ruckstuhl J
    Helv Paediatr Acta; 1970 Jul; 25(3):258-72. PubMed ID: 4996413
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion.
    Nicaise C; Gire C; Casha P; d'Ercole C; Chau C; Palix C
    Fetal Diagn Ther; 2002; 17(1):22-4. PubMed ID: 11803211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn].
    Donato H; Bacciedoni V; García C; Schvartzman G; Vain N
    Arch Argent Pediatr; 2009 Apr; 107(2):119-25. PubMed ID: 19452083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late anaemia in Rh haemolytic disease.
    Ovalý F
    Arch Dis Child Fetal Neonatal Ed; 2003 Sep; 88(5):F444; author reply F445. PubMed ID: 12937058
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anemia and edema in hemolytic disease of the newborn].
    Niedzicka E; Radomska I; Lozińska D
    Acta Haematol Pol; 1988; 19(1-2):65-70. PubMed ID: 2467500
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
    Ohls RK; Christensen RD
    J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anaemia on fetal acid-base status.
    Soothill PW; Nicolaides KH; Rodeck CH
    Br J Obstet Gynaecol; 1987 Sep; 94(9):880-3. PubMed ID: 3117096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin course in newborns with Rh hemolytic disease transfused and not transfused in utero.
    Dallacasa P; Ancora G; Miniero R; Gavella B; Brondelli L; Conte R; Salvioli GP
    Pediatr Res; 1996 Aug; 40(2):357-60. PubMed ID: 8827790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.
    Scaradavou A; Inglis S; Peterson P; Dunne J; Chervenak F; Bussel J
    J Pediatr; 1993 Aug; 123(2):279-84. PubMed ID: 8345428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.